Login / Signup
Brigatinib in ALK-Positive ALCL after Failure of Brentuximab Vedotin.
Layla Veleanu
Laurence Lamant
David Sibon
null null
Published in:
The New England journal of medicine (2024)
Keyphrases
</>
hodgkin lymphoma
advanced non small cell lung cancer